Nafamostat mesylate (INN), a synthetic serine protease inhibitor, it is a short-acting anticoagulant, and is also used for the treatment of pancreatitis... 8 KB (683 words) - 03:24, 5 October 2023 |
some medications used to treat the infection with SARS-CoV-2, namely Nafamostat and Azithromycin, ended up promoting the production of mature virions... 44 KB (5,238 words) - 09:44, 11 December 2023 |
nadolol (INN) nadoxolol (INN) nadroparin calcium (INN) nafagrel (INN) nafamostat (INN) nafarelin (INN) Nafazair (Bausch & Lomb) nafazatrom (INN) nafcaproic... 7 KB (351 words) - 09:05, 23 December 2023 |
hydroxychloroquine, interferon β-1a, and colchicine. As of 2021, favipiravir and nafamostat had shown mixed results but were still in clinical trials in some countries... 68 KB (6,412 words) - 18:38, 19 February 2024 |
non-selective inhibitor of cysteine, serine, and threonine proteases Nafamostat - inhibitor of trypsin, tryptase, and various other serine proteases Pacifastins... 3 KB (330 words) - 16:39, 9 April 2024 |
TMPRSS2-inhibitors Camostat and, in a second report by other researchers on 18 March, Nafamostat may be potential treatments as they reduced the probability of the virus... 201 KB (20,041 words) - 05:05, 15 January 2024 |